These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 6166794)

  • 1. Differential effects of dihydroergotamine on the circulatory actions of arterial and venous dilators in the rat.
    de Metz JE; van Zwieten PA
    J Cardiovasc Pharmacol; 1981; 3(2):217-27. PubMed ID: 6166794
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lower body negative pressure: a method to differentiate vasodilators in the intact rat.
    de Metz JE; van Zwieten PA
    Clin Sci (Lond); 1979 Dec; 57 Suppl 5():341s-342s. PubMed ID: 120235
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Venodilating action of nipradilol (K-351) in the pithed rat pretreated with dihydroergotamine.
    Shirasawa Y; Fujii M; Nakamura M
    Jpn J Pharmacol; 1985 Sep; 39(1):77-82. PubMed ID: 2866266
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of dihydroergotamine on hemodynamic molsidomine actions in anesthetized dogs.
    Fiedler VB; Göbel H; Nitz RE
    Can J Physiol Pharmacol; 1984 Jun; 62(6):634-9. PubMed ID: 6547632
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiovascular effects of KRN2391, nitroglycerin and cromakalim in dihydroergotamine-treated pithed rats.
    Kaneta S; Kashiwabara T; Tanaka Y; Yokoyama T; Izumi H; Izawa T; Ogawa N
    Gen Pharmacol; 1994 Sep; 25(5):963-8. PubMed ID: 7835645
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of α
    Rivera-Mancilla E; Avilés-Rosas VH; Manrique-Maldonado G; Altamirano-Espinoza AH; Villanueva-Castillo B; MaassenVanDenBrink A; Villalón CM
    J Headache Pain; 2017 Oct; 18(1):104. PubMed ID: 29022279
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of vasodilators on the systemic capacitance vessels, a study with the measurement of the mean circulatory pressure in dogs.
    Ito H; Hirakawa S
    Jpn Circ J; 1984 Apr; 48(4):388-404. PubMed ID: 6232403
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of dihydroergotamine on venous distensibility and blood pressure in idiopathic orthostatic hypotension.
    Bellamy GR; Hunyor SN
    Aust N Z J Med; 1984 Apr; 14(2):157-9. PubMed ID: 6591908
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dual effect of dihydroergotamine at vascular 5-hydroxytryptamine receptors in pithed rats.
    Müller H; Glusa E; Markwardt F
    Pharmacology; 1988; 37(4):248-53. PubMed ID: 2904153
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dihydroergotamine inhibits the vasodepressor sensory CGRPergic outflow by prejunctional activation of α
    González-Hernández A; Lozano-Cuenca J; Marichal-Cancino BA; MaassenVanDenBrink A; Villalón CM
    J Headache Pain; 2018 May; 19(1):40. PubMed ID: 29802544
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effect of dihydroergotamine (DHE) on blood volume and circulation in the calf in peridural anesthesia in the human].
    Stühmeier KD; Stanton-Hicks M; Arndt JO
    Reg Anaesth; 1987 Oct; 10(4):109-13. PubMed ID: 3685475
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of the prostanoid system in mediating the haemodynamic effects of dihydroergotamine.
    Bergqvist D; Lindblad B
    Ups J Med Sci; 1984; 89(3):227-32. PubMed ID: 6516064
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dihydroergotamine: discrepancy between arterial, arteriolar and pharmacokinetic data.
    de Hoon JN; Poppe KA; Thijssen HH; Struijker-Boudier HA; Van Bortel LM
    Br J Clin Pharmacol; 2001 Jul; 52(1):45-51. PubMed ID: 11453889
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dihydroergotamine in idiopathic orthostatic hypotension: short-term intramuscular and long-term oral therapy.
    Fouad FM; Tarazi RC; Bravo EL
    Clin Pharmacol Ther; 1981 Dec; 30(6):782-9. PubMed ID: 7030580
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Circulatory effects of dihydroergotamine in patients with disturbed sympathetic vasomotor control with special reference to postural hypotension.
    Bevegård S; Castenfors J; Lindblad LE
    Cardiology; 1976; 61 suppl 1():322-32. PubMed ID: 975147
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Haemodynamic effects of vasoactive agents following chronic state of high cardiac output in anaesthetized rats.
    Guo L; Tabrizchi R
    Eur J Pharmacol; 2008 May; 586(1-3):266-74. PubMed ID: 18367170
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardiovascular response to spinal anaesthesia in elderly men: effects of head-up tilt and dihydroergotamine administration.
    Bergenwald L; Freyschuss U; Kaijser L; Westermark L
    Clin Physiol; 1981 Oct; 1(5):453-60. PubMed ID: 7199992
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effects of nitroglycerin on exercise-induced regional myocardial contractile dysfunction are not diminished by pretreatment with dihydroergotamine.
    Schneider W; Krumpl G; Mayer N; Raberger G
    Br J Pharmacol; 1987 Sep; 92(1):87-95. PubMed ID: 3117154
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of adenosine and adenosine analogues on mean circulatory filling pressure and cardiac output in anesthetized rats.
    Tabrizchi R
    Naunyn Schmiedebergs Arch Pharmacol; 1997 Jul; 356(1):69-75. PubMed ID: 9228192
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of arteriolar vasodilators on hepatic venous compliance and cardiac output in anesthetized cats.
    Greenway CV; Innes IR
    J Cardiovasc Pharmacol; 1981; 3(6):1321-31. PubMed ID: 6173533
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.